C vs HOTH · P/E 16, rev $85.22B vs rev $1.24B
Citigroup Inc. (C) versus Hoth Therapeutics Inc (HOTH) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
C currently screens at market cap $214.73B and trailing P/E 15.5. HOTH currently screens at market cap $15.5M.
Not investment advice. Open the C and HOTH stock pages for the full models.
Not investment advice.